The CCTSI, in collaboration with Venture Partners at CU Boulder, CSU Ventures, Colorado State University and the CU Anschutz NIH funded Research Evaluation and Commercialization Hubs (REACH) programpresents Ask the Expert: adVentures in Innovation.
Dr. Jennifer Elisseeff, a Morton Goldberg Professor of Ophthalmology will discuss how Pioneering Science Meets Medical Need: Integrating Academics and Commercialization for New Therapy Translation.
Dr. Elisseeff is a Morton Goldberg Professor of Ophthalmology and the Director of the Translational Tissue Engineering Center at Johns Hopkins Department of Biomedical Engineering and the Wilmer Eye Institute with appointments in Chemical and Biological Engineering, Materials Science and Orthopedic Surgery. Elisseeff cofounded Cartilix, Inc., a startup that translated adhesive and biomaterial technologies for treating orthopedic disease, acquired by Biomet Inc. in 2009. In 2009, she also founded Aegeria Soft Tissue and Tissue Repair, new startups focused on soft tissue regeneration and wound healing. She serves on the Scientific Advisory Boards of Bausch and Lomb, Acell, Tessara therapeutics, Kythera Biopharmaceutical, and Cellular Bioengineering Inc. She has published over 120 articles, book chapters and patent applications and given over 130 national and international invited lectures.
This lunchtime series is designed for researchers and academics who are interested in entrepreneurship, pharmaceutical, device and technology development and innovation.
Each month, skillful interviewers will engage in an enlightening conversation with an expert, followed by a Q&A session.
The series will take place on Zoom.
The next session takes place Monday, June 14, 2021 at 12pm (MT).
Dr. Jennifer Elisseeff will be interviewed by Sally Hatcher, JD from Venture Partners at CU Boulder.